MHRA Inspections of CROs

pharmafile | January 24, 2012 | News story | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |  Audits, Wainwright Associates, inspectons 

In accordance with the provisions of the new pharmacovigilance legislation, as per Directive 2010/84/EU, EU Competent Authorities may inspect the premises and pharmacovigilance records of both Marketing Authorisation Holders and companies employed by them to perform pharmacovigilance services.

In the UK the MHRA is proposing to establish a scheme to carry out such inspections of service providers. Wainwright Associates’ experienced pharmacovigilance consultants are able to conduct independent audits to enable service providers to prepare for this eventuality.

For further information regarding audits and inspections, please contact us on +44 (0)1628 530554 or email enquiries@wainwrightassociates.co.uk.

Related Content

Submission of labels and leaflets in the UK

The MHRA has announced procedural changes concerning the requirement to submit full-colour mock-ups of labels …

On-going Medicine evaluation Information to be published by European Medicines Agency

Following the recommendations on transparency published by the European Heads of Medicines Agencies (HMA) and …

Payment changes of authority’s fees in France

Changes are being made in the way fees are paid for regulatory submissions and procedures …

The Gateway to Local Adoption Series

Latest content